Nucleic acid amplification device, nucleic acid amplification method and nucleic acid amplification chip
A nucleic acid amplification device with two temperature zones and a reciprocating flow path using a blower for thermal cycling addresses slow PCR issues, achieving rapid real-time PCR and multiplex analysis for on-site genetic testing.
Patent Information
- Application Number
- JP2024133977
- Authority / Receiving Office
- JP · JP
- Patent Type
- Applications
- Current Assignee / Owner
- Priority Date
- 2014-07-08
- Filing Date
- 2024-08-09
- Publication Date
- 2024-11-13
- Estimated Expiration
- 2035-07-07
AI Technical Summary
Existing nucleic acid amplification technologies, such as PCR and real-time PCR, face challenges with slow thermal cycling due to high heat capacity in aluminum blocks, require complex systems for fluorescence measurement, and are difficult to miniaturize for on-site genetic testing, especially for RNA detection and multiplex reactions.
A nucleic acid amplification device with two temperature zones and a reciprocating flow path using a blower for thermal cycling, combined with fluorescence detection, allows for high-speed real-time PCR without the need for complex pressure control mechanisms, enabling RNA conversion and multiplex analysis.
The device achieves rapid thermal cycling, enabling real-time PCR in under 10 minutes with accurate fluorescence measurement, facilitating on-site genetic testing and multiplex reactions, and is portable for clinical and outbreak settings.
Smart Images

Figure 2024160330000001 
Figure 2024160330000002 
Figure 2024160330000003
Abstract
Description
[Technical field]
[0001] The present invention relates to a nucleic acid amplification device, a nucleic acid amplification method, and a chip for nucleic acid amplification. [Background technology]
[0002] Nucleic acid detection is central to many fields, including pharmaceutical research and development, forensic science, clinical testing, identification of agricultural crops and pathogenic microbial species, etc. The ability to detect various diseases including cancer, microbial infections, and genetic markers based on molecular phylogenetic analysis has made it a universal technology for disease and risk diagnosis, marker discovery, food and environmental safety assessment, criminal proof, and many other technologies.
[0003] One of the most powerful basic technologies for highly sensitive detection of small amounts of nucleic acid, i.e. genes, is a method for exponentially replicating and amplifying a part or all of a nucleic acid sequence and analyzing the products.
[0004] PCR is a powerful technique for selectively amplifying a specific region of DNA. Using PCR, millions of copies of a DNA fragment of a target DNA sequence can be generated from a single template DNA. PCR involves repeated three- or two-phase temperature conditions called thermal cycles, which sequentially repeat the individual reactions of denaturing DNA into a single strand, annealing the denatured DNA single strand with a primer, and elongating the primer with a thermostable DNA polymerase enzyme. This cycle is repeated until a sufficient number of copies is obtained for analysis. In principle, it is possible to double the number of copies in one cycle of PCR. In practice, the thermal cycles As the reaction continues, the accumulation of the amplified DNA product eventually stops as the concentrations of the necessary reaction reagents decrease. For general details of PCR, see Clinical Applications of PCR, Dennis Lo (ed.), Humana Press, Totowa, NJ (1998), and PCR Protocols A Guide to Methods and Applications, MA Innis et al. (eds.), Academic Press Inc., San Diego, CA (1990).
[0005] PCR is a powerful method that can selectively amplify the target DNA, but in order to confirm the amplified DNA, a separate confirmation step such as gel electrophoresis was required after the end of PCR. Therefore, as an improvement to PCR, real-time PCR, which generates or quenches fluorescence according to the amount of amplified target DNA, has been developed, making it easy to confirm the presence or absence of target DNA in a sample. In conventional PCR, when the amount of template DNA in a sample before PCR exceeds a certain amount, the amount of amplified DNA after PCR often reaches a plateau, making it impossible to quantify the amount of template DNA before PCR. However, in real-time PCR, the amount of amplified DNA during PCR can be detected in real time before the plateau is reached, making it possible to quantify the amount of template DNA before PCR from the state of DNA amplification. Therefore, real-time PCR is also called quantitative PCR.
[0006] The quantitative nature of target DNA using real-time PCR is particularly useful in clinical settings. For example, it is used to monitor the change in viral load when confirming the effectiveness of treatment for viral infections such as the AIDS virus (HIV).In addition, DNA quantification by real-time PCR is also effective in diagnosing opportunistic infections such as the herpes virus (HHV), many of which are asymptomatically infected from early childhood but which grow and develop as a result of physical decline.
[0007] PCR and real-time PCR methods use thermal cycling to exponentially grow genes. PCR is a powerful method for amplifying DNA, but the general-purpose thermal cycler used in PCR has slow temperature control due to the huge heat capacity of the aluminum block that acts as a heater, and traditionally it takes 1-2 hours, and sometimes even longer, to perform 30-40 PCR cycles. As a result, even with the latest genetic testing equipment, a total analysis usually takes more than an hour, and speeding up PCR operations has been a major challenge since the technology was introduced. Various methods have been developed to achieve speedups, but the thermal cycling of samples can be classified into the following three methods:
[0008] In the first method, a sample solution is introduced into the device, and temperature cycling is performed over time while the solution is kept in the same place (Non-Patent Document 1 and Patent Document 1). This method aims to reduce the heat capacity by reducing the amount of sample, and to speed up the thermal cycle, but since there is a limit to how much the heat capacity of the chamber and heater themselves can be reduced, at least about 30 seconds per cycle is required to perform a sufficient amplification reaction, and even the fastest device must spend 15 minutes or more to complete the PCR reaction.
[0009] The second method is called continuous flow PCR, in which the sample liquid moves through a plurality of temperature zones that are spatially separated through a microchannel, and the sample liquid is continuously fed without stopping. Among the continuous flow PCR methods, a method is known in which the sample temperature is controlled at high speed by flowing the sample through a serpentine flow channel over three heaters controlled at a constant temperature (Non-Patent Document 2). Since this continuous flow PCR method does not require temperature changes in external devices such as containers and heaters, the theoretically fastest temperature control can be expected, and DNA amplification can be achieved in about 7 minutes in an extremely fast case. However, in order to perform quantitative real-time PCR using continuous flow PCR, a mechanism is required that can observe the fluorescence of the entire region of the serpentine flow channel, or 30 to 50 regions of the serpentine flow channel in the same temperature zone, in order to measure the fluorescence intensity of each thermal cycle. Specifically, an excitation light source that can uniformly irradiate a wide area and a highly sensitive video camera or line scanner for fluorescence observation are required, which inevitably results in a large and expensive system configuration.
[0010] In the third method, similar to the second method, a plurality of temperature zones separated by space are connected by a microchannel, and the sample liquid is heated by repeatedly moving alternately through the same channel so as to stop at these temperature zones for a predetermined time each time (Patent Document 2). This method is advantageous in that the time of contact with each temperature zone can be freely set to perform thermal cycling. However, in order to introduce a sample and use a pump to send it to these temperature zones in a reciprocating or rotating manner, when the sample solution moves through the channel in which a temperature gradient is formed from about 95°C or higher for the denaturation reaction to about 60°C for the annealing reaction, the expansion of minute bubbles generated in the sample heated on the high temperature side and the vapor pressure difference generated at the gas-liquid interface cause the solution to move unintentionally from the desired temperature region position in the channel. In order to prevent this, it is necessary to have a large number of integrated valves and pumps, as well as a detector for observing the solution position, which makes it difficult to miniaturize the device (Non-Patent Documents 3, 4 and Patent Document 5). Reference 3).
[0011] The market for genetic testing using PCR / real-time PCR devices is growing steadily, and genetic testing for infectious diseases such as viral hepatitis, sexually transmitted diseases, and influenza is particularly beginning to spread rapidly in Japan. As the usefulness of genetic testing in cancer treatment has become clear, such as EGFR gene mutations being an indication for the application of the anticancer drug Iressa, genetic testing for the EGFR gene, K-ras gene, EWS-Flil gene, TLS-CHOP gene, SVT-SSX gene, and c-kit gene in lung cancer, pancreatic cancer, etc. has recently become covered by health insurance.
[0012] In PCR, a primer is attached to the template DNA, and DNA polymerase is used to specifically detect the DNA sandwiched between the target primer sequences. PCR can be used to detect DNA, but it cannot directly detect RNA. Therefore, in order to detect RNA viruses such as influenza virus and norovirus, RNA is required. Using A as a template, complementary cDNA is first synthesized using reverse transcriptase, and then PCR is performed. In this method, a so-called RT-PCR method is performed, which essentially requires two steps. In addition, the PCR method and the RT-PCR method require rapid temperature increase and decrease, which requires a special incubator, and there is a problem that it is not easy to apply it to automation.
[0013] In recent years, attention has been focused on multiplex PCR, which uses multiple primer pairs in one PCR reaction system to simultaneously amplify multiple gene regions. Real-time multiplex PCR, an advanced version of multiplex PCR, aims to distinguish and detect multiple different target genes without reducing sensitivity and each target is less susceptible to crosstalk with other targets, thereby obtaining quantitative results. However, due to issues such as the types of fluorescent substances that can be labeled and overlapping fluorescent wavelengths, it is difficult to use multiple types of fluorescent substances to amplify multiple gene regions simultaneously. Quantitative multiplex reactions have been reported to be difficult, and often impossible.
[0014] Currently, genetic tests are carried out by taking samples back to a laboratory or analysis center, but if there were a high-speed real-time PCR device that could be used quickly on-site, treatment and countermeasures could be decided on the spot, making this a groundbreaking technology that could replace current genetic testing equipment. In particular, in border control measures for pandemics such as foot-and-mouth disease and highly pathogenic influenza, it is important to be able to make quick and accurate judgments on-site and to prevent the secondary spread of infection due to movement, and there is an extremely high need for such measures.
[0015] In particular, to realize a service that allows for immediate genetic testing at clinical or infectious disease outbreak sites, a real-time PCR device that can be implemented at low cost and is fast and highly portable is required. [Prior art documents] [Patent documents]
[0016] [Patent Document 1] Canadian Patent Application Publication No. 2479452 [Patent Document 2] Patent Publication No. 2003-200041 [Patent Document 3] WO2006 / 124458 [Non-patent literature]
[0017] [Non-Patent Document 1] Neuzil et al. (Lab Chip 10:2632-2634 (2010)) [Non-Patent Document 2] Kopp et al. (Science 280:1046-1048 (1998)) [Non-Patent Document 3] Chiou et al. (Anal Chem 73:2018-2021 (2001)) [Non-Patent Document 4] Brunklaus et al. (Electrophoresis 33:3222-3228 (2012)) Summary of the Invention [Problem to be solved by the invention]
[0018] An object of the present invention is to provide a nucleic acid amplification device that is small and portable to the site, and that is capable of performing real-time PCR at high speed, a plate for the device, and a nucleic acid amplification method. [Means for solving the problem]
[0019] In order to achieve efficient reactions and to realize a compact amplification device, the present invention arranges two temperature zones on a plane, brings the flow paths into close contact with each of the temperature zones, and performs thermal cycling by moving plug-shaped sample solutions back and forth at precise positions on each temperature zone within the flow path by a liquid delivery mechanism that is opened to atmospheric pressure when a blower or fan is stopped at both ends of the flow path, and at this time, the passage of the PCR solution is confirmed and the fluorescence intensity is measured for each thermal cycle at the same time. In another exemplary embodiment, the nucleic acid amplification method includes converting RNA into cDNA by reverse transcription and performing PCR on the cDNA.
[0020] That is, the present invention provides the following nucleic acid amplification device, nucleic acid amplification method, and chip. (1) A reciprocal flow type nucleic acid amplification device comprising a heater capable of forming a denaturation temperature zone and an extension / annealing temperature zone, a fluorescence detector capable of detecting the movement of a sample solution between the two temperature zones, a pair of liquid delivery mechanisms that enable the movement of the sample solution between the two temperature zones and are released to atmospheric pressure when liquid delivery is stopped, a substrate on which a nucleic acid amplification chip can be mounted, and a control mechanism that receives an electric signal from the fluorescence detector related to the movement of the sample solution and controls the drive of each liquid delivery mechanism, and performs real-time PCR by measuring the fluorescence intensity for each thermal cycle. (2) A nucleic acid amplification chip having at least one microchannel having curved channels corresponding to the denaturation temperature zone and the extension / annealing temperature zone in the nucleic acid amplification device of (1), a straight intermediate channel connecting the curved channels, and connectors at both ends of the channel that can be connected to the liquid delivery mechanism in the nucleic acid amplification device of (1). (3) The nucleic acid amplification apparatus according to (1), wherein the liquid delivery mechanism is a microblower or a blower. (4) A method for amplifying a nucleic acid, comprising the steps of: Step 1: placing the nucleic acid amplification chip according to (2) on the substrate according to (1) so that a curved flow path is included in each of a denaturation temperature zone and an extension / annealing temperature zone; Step 2: introducing a sample solution into the microchannel; Step 3: connecting the liquid delivery mechanism connectors at both ends of the microchannel to the pair of liquid delivery mechanisms; Step 4: A step of performing thermal cycling by using the liquid delivery mechanism to move the sample solution back and forth between two curved flow paths of the microchannel, and further performing real-time PCR by simultaneously measuring the fluorescence intensity of the sample solution for each thermal cycle and confirming the passage of the sample solution using the fluorescence detector in the intermediate flow path. (5) The method according to (4), characterized in that the measurement of the fluorescence intensity is performed by simultaneously measuring two or more types of fluorescence wavelengths and simultaneously measuring real-time PCR of a plurality of genes in a single flow channel. Nucleic acid amplification methods. (6) The nucleic acid amplification method according to (4) or (5), characterized in that the measurement of the fluorescence intensity is carried out using a calibration curve obtained from cycle number Ct values derived from a matrix of fluorescence intensity for each thermal cycle number (two-dimensional array of amplification curves). (7) The method for amplifying nucleic acid according to any one of (4) to (6), wherein the method for amplifying nucleic acid is selected from the group consisting of polymerase chain reaction (PCR), reverse transcription PCR (RT-PCR), multiplex PCR or RT-PCR, and real-time PCR or RT-PCR. (8) The nucleic acid amplification method according to any one of (4) to (7), characterized in that two or more of the flow channels are formed on a planar substrate, and each flow channel can be independently operated for liquid delivery, thereby performing interrupt analysis. (9) The nucleic acid amplification method according to any one of (4) to (8), wherein a tip of a filter-equipped pipette tip of a micropipette is connected to the connection part to introduce a sample solution into a microchannel, the micropipette is removed with the pipette tip connected to the connection part, and then the pipette tip is connected to the liquid delivery mechanism. (10) The volume of the sample solution introduced into the flow channel is in the range of 5 μL to 50 μL. The method for amplifying nucleic acid according to any one of (4) to (9), (11) The nucleic acid amplification chip according to (2), which is used in any one of the nucleic acid amplification methods (4) to (10). Effect of the Invention
[0021]
[0022] In addition, because the sample solution travels back and forth between two temperature zones, the passage of the PCR solution can be confirmed and the fluorescence intensity can be measured for each thermal cycle simultaneously and at high speed, thereby achieving high-speed real-time PCR.
[0023] In the conventional method using thermal cycles by the reciprocating motion of a sample solution, a pressure source such as a syringe pump is connected to a flow channel, and the plug-shaped sample solution is sent back and forth by repeatedly applying pressure and pressure. In this case, the inside of the flow channel connected to the pressure source must be a closed system so that pressure does not escape from the plug-shaped sample solution in the flow channel. The liquid is sent when the force acting on the gas-liquid interface of the plug-shaped sample solution caused by the pressure or pressure reduction of the pressure source exceeds the static friction force between the plug-shaped sample solution and the inner wall of the flow channel. On the other hand, when the pressure or pressure reduction is stopped to stop the plug-shaped sample solution, the pressure acting on the gas-liquid interface of the sample solution remains inside the closed flow channel on the pressure source side at that time, and the plug-shaped sample solution continues to move for a while until the energy is consumed by kinetic friction, and then it stops. In particular, when heating to approximately 95°C or above for a denaturation reaction such as PCR, the effects of fluctuations in the internal pressure of the sample solution, such as changes in viscosity and the generation of tiny bubbles, are significant, and the amount of movement after the pressure source such as a pump is stopped varies greatly. In order to stop the sample solution in an accurate position, it was necessary to use a dedicated valve to release the pressure inside the flow path, complex operation of the pressure source, and multiple dedicated sensors to confirm the solution position.
[0024] However, in the present invention, the reciprocating flow of the plug-shaped sample solution is carried out by pressurizing or depressurizing the inside of the flow channel by blowing air from a blower or fan, etc., but if the blower or fan is stopped at the point when the sample solution reaches the correct position on the temperature zone or just before that, the pressure inside the flow channel is instantly released to atmospheric pressure, and the pressure acting on the plug-shaped sample solution is lost, so the flow stops immediately. Therefore, even if there are no multiple valves for releasing pressure to control the position of the sample solution, accurate position control is possible by simply checking the passage of the sample solution at one point between each temperature zone. Furthermore, since fluorescence measurement can be performed simultaneously at the point where the position of each cycle of reciprocating flow is confirmed, a real-time PCR thermal cycler with the simplest configuration can be realized, with only one point on the linear flow channel as the detection point.
[0025] The present invention utilizes the polymerase chain reaction, called PCR, which uses multiple cycles of denaturation, annealing of primer pairs to opposite strands, and extension of the primers resulting in an exponential increase in the number of copies of a target nucleic acid sequence. In a variation of it, called reverse transcription PCR (RT-PCR), reverse transcriptase (RT) is used to generate complementary DNA (cDNA) from mRNA, which is then amplified by PCR to generate multiple copies of DNA.
[0026] In addition, one-step RT-PCR can also be used for the RT-PCR reaction. One-Step RT-PCR is a method that starts with incubation at RT and ends with incubation at PCR. This is an RT-PCR method that allows RT-PCR to be performed quickly and easily in one step without opening and closing tubes or adding reagents until cycling. Various kits and protocols for One-Step RT-PCR are available in the art. (For example, QIAGEN's OneStepRT-PCRMix, etc.) can.
[0027] For various other variations on PCR, see, e.g., U.S. Patent Nos. 4,683,195, 4,683,202, and 4,800,159; Mullis et al., Meth. Enzymol. 155:335 (1987); and Murakawa et al., DNA 7:287 (1988), each of which is incorporated herein by reference in its entirety. is incorporated into the book. [Brief description of the drawings]
[0028] [Figure 1] FIG. 1 is a diagram showing a device configuration of a nucleic acid amplification device. [Diagram 2] FIG. 1 is a diagram showing the configuration of a PCR chip. [Diagram 3] FIG. 1 shows the amplification of nucleic acids in high-speed real-time PCR. [Figure 4] This shows the standard curve for E. coli used in high-speed real-time PCR. [Diagram 5] This figure shows a plot of the retention time at which the Ct value does not change and the target DNA can be sufficiently amplified, even when the annealing and extension reaction times are shortened, for each length of target DNA. [Figure 6] Pathogenic microorganisms A and B and β-actin gene multiplex PCR are shown. [Figure 7] FIG. 1 shows the nucleic acid amplification of RNA having the G1 gene sequence or G2 gene sequence of norovirus in rapid one-step reverse transcription real-time PCR using different reverse transcriptases. [Figure 8] FIG. 1 shows the amplification of nucleic acids from different initial concentrations of RNA having the norovirus G1 gene sequence or G2 gene sequence in rapid one-step reverse transcription real-time PCR. [Figure 9] The figure shows a calibration curve using the Ct value, the cycle number at which fluorescence intensity increases rapidly in rapid one-step reverse transcription real-time PCR for RNA having the G1 gene sequence or G2 gene sequence of norovirus. DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS
[0029] Hereinafter, one embodiment of the reaction apparatus of the present invention will be described with reference to FIGS.
[0030] As shown in Figure 1, the device configuration used for high-speed real-time PCR consists of a substrate (not shown) for mounting the PCR chip, a temperature control unit for the PCR chip, a liquid delivery microblower as a liquid delivery mechanism, a fluorescence detector, a control computer as a control mechanism, and a small battery for power supply.
[0031] The temperature control unit for the PCR chip is configured by arranging two cartridge heaters in parallel at an interval of 10 mm so that they are in contact with the sealing surface side of the meandering flow path of the PCR chip without any gaps. To control the temperature of the two heaters, a K-type thermocouple is connected to each heater. do.
[0032] The cartridge heater 1 is controlled by a control computer to a temperature required for the DNA denaturation reaction required for PCR, and the temperature (denaturation temperature range) is preferably 90 to 100°C, and more preferably 95°C. The cartridge heater 2 is used for the DNA annealing reaction and extension reaction. The temperature range for DNA denaturation reaction, annealing reaction, and extension reaction is preferably controlled to a constant temperature by a control computer, and the temperature range for DNA denaturation reaction, annealing reaction, and extension reaction is preferably controlled to a constant temperature by, for example, PID (proportional-integral-derivative) control.
[0033] The required amount of PCR solution to be delivered is measured using a micropipette or the like, within the range of 5 to 50 μL, preferably 5 to 25 μL, and the disposable tip of the micropipette is attached to one end of the microchannel while still containing the PCR sample solution. The sample solution can also be injected into the microchannel of the PCR chip by removing the micropipette body and instead connecting an air pressure tube connected to a liquid delivery microblower and applying pressure by blowing air.
[0034] The PCR sample solution is prepared by pre-assembly with a probe called TaqMan probe, Cycleave probe, or E probe (registered trademark) together with the components necessary for PCR to enable real-time PCR. The fluorescent probes are mixed with fluorescent dyes such as SYBR GREEN, etc. These fluorescent probes can be purchased from real-time PCR reagent kits or outsourced synthetic products.
[0035] The fluorescence detector is positioned so as to measure the fluorescence intensity at a single detection point on the straight flow path located at the center of each micro-flow path. When the PCR solution is pumped from one of the serpentine flow path sections by pressurization and has passed the detection point, the liquid-pumping microblower is stopped and the PCR solution is retained in the other serpentine flow path section for a certain period of time.
[0036] The control computer can simultaneously program and control two microblowers connected to each microchannel, and performs thermal cycling by alternately switching the microblowers so that the PCR sample solution moves alternately to the meandering channel section above each heater for a set time while continuously monitoring the fluorescence intensity at the detection point at the center of each microchannel. The control computer also simultaneously records the change in fluorescence intensity for each cycle that increases as the target DNA is amplified by thermal cycling in the real-time PCR method, and can quantify the initial amount of target DNA by calculating the cycle number (Ct value) at which the fluorescence intensity exceeds a certain threshold.
[0037] The PCR chip (nucleic acid amplification chip) used for high-speed real-time PCR has a structure in which a COP resin substrate with four microchannels formed in parallel by injection molding is bonded to a transparent polyolefin seal.
[0038] Each microchannel has a width and depth of 700 μm and a structure that meanders and turns back at two points, as shown in Figure 2. Each meandering channel portion is folded back four times to sandwich the straight channel portion at the center of the microchannel, and each meandering channel portion alone can accommodate at least 25 μL of solution.
[0039] In Figure 2, the regions enclosed by dotted lines (denaturation temperature zone and extension / annealing temperature zone) are heated by heaters for thermal cycling in real-time PCR.
[0040] Both ends of the flow path are individually connected to small holes (connections to the liquid delivery mechanism) that penetrate the resin substrate, and even after the entire surface of the microchannel side of the resin substrate is bonded with a transparent polyolefin seal, conduction of reaction solution and air is possible through the small holes for each microchannel.
[0041] The small hole is designed to accommodate disposable micropipette tips commonly used in biochemistry experiments, and can be used as is after measuring 5 to 25 μL of PCR solution. By connecting the chip, a dedicated tool is not required and the PCR solution can be introduced without contamination.
[0042] In addition, by forming two or more of the flow paths on a planar substrate, or by arranging two or more planar substrates having the flow paths in parallel, it is possible to perform an interrupt analysis by allowing independent liquid delivery operations for each flow path.
[0043] The flow channel is preferably made of a material that has relatively high thermal conductivity, is stable in the temperature range required for PCR, is not easily corroded by electrolyte solutions or organic solvents, and does not adsorb nucleic acids or proteins. Examples of materials include glass, quartz, silicon, and various plastics. The shape of the flow channel that comes into contact with multiple temperature regions may be a straight flow channel, or a curved flow channel such as a meandering flow channel having a loop shape or a spiral flow channel. Furthermore, the width or depth of the flow channel does not have to be constant, and the width or depth may vary partially.
[0044] It is preferable that the same fluorescence detector is used to detect the passage of the sample solution in the flow path to different temperature regions and to measure the fluorescence intensity for each thermal cycle, but it is also possible to include multiple different fluorescence detectors. Methods for detecting the passage of the sample solution between multiple temperature regions include optical methods such as colorimetry and light absorption, changes in capacitance, electrochemical reactions, etc., in addition to fluorescence detection. The two or more temperature regions in contact with the flow path may be in contact with the outside of the flow path, or may be built in the inside of the flow path.
[0045] In the microchannel shown in Figure 2, two serpentine channels corresponding to the denaturation temperature zone and the extension / annealing temperature zone are connected by a straight intermediate channel, and the passage of the sample solution and fluorescence are detected in the intermediate channel. In Figure 2, the intermediate channel is placed on the straight line connecting the two small holes (connection parts of the liquid delivery mechanism), and the passage of the sample solution and fluorescence are detected in this intermediate channel, so detection with a fluorescence detector is possible even if the PCR chip (chip for nucleic acid amplification) is placed upside down (rotated 180 degrees) on the substrate.
[0046] Before use, the PCR chip may be fixed to each of these two heaters so that the sealing surfaces of each meandering channel part surrounded by dotted lines are in close contact as shown in Figure 2, and after use, the chip may be removed and replaced for disposable use. Two liquid-transporting microblowers are used for each microchannel on the PCR chip, and one is connected to each disposable chip connected to both ends of the microchannel via an air pressure tube, and these are operated mutually to achieve bidirectional liquid transport. In addition, the number of liquid-transporting microblowers can be increased according to the number of microchannels to simultaneously thermocycle multiple different samples, for example, to perform multiplex PCR.
[0047] In the present invention, multiplex PCR refers to PCR in which a primer set containing two or more types of forward primers is used in the same reaction solution. In the present invention, a "primer set" refers to a combination of one or more types of forward primers and reverse primers. Here, even if the primer set according to the present invention contains only one type of reverse primer, it can be used as a primer set for multiplex PCR when the reverse primer generates separate amplification products in combination with two or more types of forward primers (as a primer pair).
[0048] In the multiplex PCR of the present invention, the amplification of the target genes corresponding to each fluorescence wavelength is detected by simultaneously measuring the fluorescence intensity. Detection may be performed using multiple fluorescence detectors, but detection signals using light of one wavelength are also possible. EXAMPLES
[0049] The present invention will be described in detail below with reference to examples, but the scope of the present invention is not limited to these examples.
[0050] [Example 1] Quantification of Escherichia coli Using a PCR chip for high-speed real-time PCR and the device of the present invention, Escherichia coli (E. coli) was quantified. E. coli (DH5α strain) was cultured overnight in lecithin broth liquid medium and then plated on an agar plate. Based on colony counts by laboratory, 1 × 10 4 After preparing a suspension of E. coli cfu / μL, dilute it 10-fold. A series of analyses was prepared and used as standard samples for quantitative confirmation.
[0051] The target DNA amplified in real-time PCR is the E. coli specific uid A gene (A The 106 bp DNA sequence of the PCR product was used as the forward primer for PCR. the reverse primer was 5'-GTG TGA TAT CTA CCC GCT TCG C-3' (SEQ ID NO: 1); The sequence of the probe used was 5'-AGA ACG GTT TGT GGT TAA TCA GGA-3' (SEQ ID NO: 2), and the final concentration of each probe in the PCR solution was 300 nM. The sequence of the TaqMan (registered trademark) probe for real-time PCR was 5'-FAM-TCG GCA TCC GGT CAG TGG CAG T-MGB-3' (SEQ ID NO: 3), and the final concentration in the PCR solution was 200 nM.
[0052] As for other reagents, Takara Bio's SpeedSTAR® HS DNA polymerase was used at a final concentration of 0.1 U / μL, and the included FAST Buffer I and dNTP Mixture were used according to the manual. The mixture was mixed at the following concentrations to prepare a premix for PCR. 0.5 μL of E. coli suspension at each concentration The PCR solution was mixed with 12 μL of the PCR premixture by a micropipette, and the tip of the disposable tip of the micropipette was inserted into a small hole at one end of the microchannel of the PCR chip while the PCR solution was being aspirated, and the disposable tip and the micropipette were released. An empty disposable tip for micropipette was also attached to the other end of the microchannel equipped with the disposable tip for micropipette containing the PCR solution, and a tube for a liquid-sending microblower was connected to each of them. The thermal cycle conditions for the high-speed real-time PCR were set to 98°C for 30 seconds for hot start of DNA polymerase, followed by 45 cycles of 98°C for 2 seconds and 58°C for 4 seconds, and the high-speed real-time PCR was performed by program control of the liquid-sending microblower.
[0053] As shown in Figure 3, the fluorescence intensity per cycle in high-speed real-time PCR follows a sigmoid curve similar to that of existing real-time PCR devices, and the rate of fluorescence amplification changes depending on the initial concentration of E. coli.
[0054] The Ct value is the cycle number at which the fluorescence intensity crosses an arbitrary threshold value. When a calibration curve is plotted against the initial concentration of E. coli, good linearity is obtained as shown in Figure 4. Since the Ct value of the control (NTC) was 45 cycles or higher, it was confirmed that quantification was possible even at a concentration of 100 cfu / μL, and that the detection sensitivity was equivalent to that of existing real-time PCR devices.
[0055] The processing time for high-speed real-time PCR is 6 minutes and 40 seconds for 45 cycles, which is longer than that of existing commercially available equipment. Even with the fastest thermal cycler, the processing time for 45 cycles was 45 minutes, achieving high-speed real-time PCR that enables extremely rapid quantification of microorganisms and DNA.
[0056] [Example 2] Examination of high-speed PCR conditions High-speed real-time PCR involves a DNA denaturation reaction, an annealing reaction, and an extension reaction in which DNA polymerase replicates the 3' end of each primer along the template DNA sequence. The reaction is carried out by repeating three steps. Among them, the DNA denaturation reaction and the annealing reaction are completed in a short time, independent of the length of the target DNA. However, the extension reaction requires time depending on the length of the target DNA and the enzyme activity of the DNA polymerase, so even in high-speed real-time PCR, appropriate time setting of the thermal cycle is required.
[0057] 10 of the 16S ribosomal RNA gene of Escherichia coli (DH5α strain) (accession number KC_768803.1) 4 The copies were used as template DNA, and 45 cycles of high-speed real-time PCR was performed with the target DNA length varied from approximately 200 to 800 bp.
[0058] The common forward primer sequence was 5'-GTT TGA TCC TGG CTC A-3' (SEQ ID NO: 4), the common TaqMan® probe sequence was 5'- FAM-CGG GTG AGT AAT GTC TGG-TAMRA-3' (SEQ ID NO: 5), and the following reverse primers were used according to the length of the target DNA: Used together. The reverse primer sequence for a target DNA length of approximately 200 bp is 5'-CTT TGG TCT TGC GAC G-3. ' (SEQ ID NO: 6), the sequence of the approximately 400 bp reverse primer is 5'-GCA TGG CTG CAT CAG-3' (SEQ ID NO: 7), the reverse primer sequence of approximately 600 bp was 5'-CTG ACT TAA CAA ACC GC-3' (SEQ ID NO: 8), and the reverse primer sequence of approximately 800 bp was 5'-TAC CAG GGT ATC TAA TCC-3' (SEQ ID NO: 9), and the Tm values of all were set to approximately 50°C.
[0059] Even if the annealing and extension reaction times are shortened, the Ct value does not change and the target DNA is sufficiently amplified. Figure 5 shows a graph plotting the retention time for each length of target DNA. For short target DNA of about 100 bp, the results of the uid A gene described above were used and plotted on the same graph. As can be seen from Figure 5, even for the same target DNA length, the annealing and extension reaction times differ depending on the activity of the DNA polymerase, with the time being approximately 78 bp per second for SpeedSTAR (registered trademark) HS DNA polymerase and approximately 22 bp per second for ExTaq HS DNA polymerase.
[0060] Furthermore, the theoretical annealing reaction time excluding the extension reaction was approximately 2.7 seconds regardless of the type of DNA polymerase when the target DNA length was 0 bp, which corresponds to the X-intercept in Figure 5. This is consistent with the previously mentioned conventional knowledge, so by setting the time based on Figure 5 according to the length of the target DNA, it is possible to carry out the theoretically fastest real-time PCR.
[0061] [Example 3] Multiplex PCR As an example of application to multiplex PCR, which checks for the presence or absence of multiple target DNAs from the same sample in high-speed real-time PCR, a multicolor fluorescent detector capable of simultaneously measuring three types of fluorescence was developed. Using a photodetector, we investigated the simultaneous detection of Neisseria gonorrhoeae, Chlamydia trachomatis, and the human leukocyte-derived β-actin gene.
[0062] The multi-color fluorescence detector can quantitatively measure the fluorescence of blue, green, and red excitation on the same axis, and three types of FAM-labeled, Texas red-labeled, and Cy5-labeled are detected at the same detection point of the microchannel on the PCR chip. The fluorescence amplification by the fluorescent probes can be detected individually. When using a multicolor fluorescence detector, one point on the straight flow path located at the center of each microchannel is used as the detection point, and the three types of fluorescence intensity are measured simultaneously. When the PCR solution delivered from the row flow path section has passed through the detection point, the liquid delivery microblower is stopped and the PCR solution can be retained in the other serpentine flow path section for a certain period of time.
[0063] The lengths of the target DNA for Neisseria gonorrhoeae, Chlamydia trachomatis, and the β-actin gene, and the Tm values for each primer and fluorescent probe were all identical, and the primers and fluorescent probes were designed to have no difference in amplification efficiency.
[0064] The fluorescent probes for Neisseria gonorrhoeae and Chlamydia trachomatis, and the β-actin gene were Texas red, Cy5, and FAM-labeled TaqMan® probes, respectively. were used, and the final concentration in the PCR solution was 200 nM each.
[0065] The final concentrations of the PCR solution for Neisseria gonorrhoeae, Chlamydia trachomatis, and three types of forward and reverse primers for the β-actin gene were 300 nM each. Other reagents were SpeedSTAR® HS (Takara Bio) DNA polymerase was used at a final concentration of 0.2 U / μL, and the included FAST Buffer I and dNTP Mixture were mixed at the concentrations specified in the manual to prepare a premix for PCR.
[0066] Neisseria gonorrhoeae and Chlamydia trachomatis, and the β-actin-specific For the target DNA, synthetic plasmids containing each target DNA sequence were prepared, and 4 ng / μL was used as a positive control, and sterilized water was used as an NTC. carried out. The thermal cycle conditions were a hot start at 96°C for 20 seconds, followed by another 3 seconds at 96°C and 60°C. The thermal cycle for 45 cycles was set to 8 seconds at 45 cycles. The total run time was 9 minutes and 40 seconds.
[0067] Neisseria gonorrhoeae and Chlamydia trachomatis using rapid real-time PCR The results of multiplex PCR for the β-actin gene are shown in Figure 6. Note that the sensitivity of the multicolor fluorescence detector to the three fluorescent dyes is different, so the dynamic range was corrected. In Figure 6, the thick lines indicate the results for each of the three types of DNA containing template DNA. The change in fluorescence intensity of each compound is shown in Fig. 1. Compared to the fluorescent signal of NTC, which is shown by the thin line, a clear amplification was observed. Simultaneous measurement of multiple items from the same sample has been achieved.
[0068] By simultaneously measuring the three types of fluorescence intensity, The amplification of the target gene is detected. When the PCR solution is sent from one of the serpentine flow paths by pressure and the passage of the solution is detected by stopping the microblower when the solution has passed through the detection point, it is not necessary to use all the fluorescence detectors, and a detection signal using light of any one wavelength can be used.
[0069] [Example 4] One-step reverse transcription real-time PCR A method in which reverse transcriptase is mixed in advance with a PCR solution and reverse transcription from RNA and real-time PCR are easily performed from one reaction solution is called one-step reverse transcription real-time PCR, and is used to detect RNA viruses such as influenza virus and norovirus. In one-step reverse transcription real-time PCR, the operation can be significantly simplified by combining two steps of the general RT-PCR method, but the reverse transcriptase of the reverse transcription reaction and the DNA polymerase of the real-time PCR method interfere with each other, which is a problem in that the efficiency of PCR decreases. However, by quickly shifting to the optimal temperature for the activity of the reverse transcriptase and the DNA polymerase by high-speed temperature control, the reverse transcription reaction and the real-time PCR method can be performed efficiently and in order, making it possible to perform a highly efficient one-step reverse transcription real-time PCR. In fact, the quantification of the G1 gene and G2 gene of norovirus by one-step reverse transcription real-time PCR was examined using a PCR chip for high-speed real-time PCR and the device of the present invention.
[0070] The RNA containing the target G1 or G2 gene sequence was either a standard provided with the commercially available TaKaRa qPCR Norovirus (GI / GII) Typing Kit or a transcript of synthetic DNA. Using RNA, a dilution series was prepared using RNase-free sterile water.
[0071] The primer and probe sequences used were those described in the Norovirus Detection Method provided by the Infectious Disease Information Center of the National Institute of Infectious Diseases. The forward primer sequence for the G1 gene of norovirus was 5'-CGY TGG ATG CGN TTY CAT GA-3' (SEQ ID NO: 10) of COG-1F. The TaqMan® probe sequences were 5'-AGA TYG CGA TCY CCT GTC CA-3' (SEQ ID NO: 11) for RING1-TP(a) and 5'-AGA TCG CGG TCT CCT GTC CA-3' (SEQ ID NO: 12) for RING1-TP(b), and the reverse primer sequence was 5'-CTT AGA CGC CAT CAT CAT TYA C-3' (SEQ ID NO: 13) for COG-1R. The primer sequence is 5'-CAR GAR BCN ATG TTY AGR TGG ATG AG-3' (SEQ ID NO: 14) of COG-2F. ), the TaqMan (registered trademark) probe sequence was 5'-TGG GAG GGS GAT CGC RAT CT-3' (sequence number 15) of RING2AL_TP, and the reverse primer sequence was 5'-TCG ACG CCA TCT TCA TTC ACA-3' (sequence number 16) of COG-2R.
[0072] The fluorescent probes for the G1 gene and the G2 gene were both FAM-labeled TaqMan (registered trademark) probes were used, with the final concentration in the PCR solution being 200 nM each.
[0073] The final concentration of each forward primer and reverse primer for the G1 gene or G2 gene in the PCR solution was 300 nM. Other reagents included PrimeScript® Reverse Transcriptase from Takara Bio or SuperScript® Reverse Transcriptase from Life Technologies at a final concentration of 5 U / μL, RNase inhibitor at a final concentration of 1 U / μL, and SpeedSTAR® HS DNA polymerase at a final concentration of 0.2 U / μL. The kit was used and the included FAST Buffer I and dNTP Mixture were mixed at the concentrations specified in the manual to prepare a premix for one-step reverse transcription real-time PCR.
[0074] The thermal cycle conditions were 42°C for 10 seconds when Takara Bio's PrimeScript® Reverse Transcriptase was used for the reverse transcription reaction, or 55°C for 10 seconds when Life Technologies' SuperScript® Reverse Transcriptase was used. These reverse transcription reactions were carried out in a serpentine flow channel located above the low-temperature heater in a PCR chip for high-speed real-time PCR, and after the reverse transcription reaction was completed, the temperature of the low-temperature heater was raised to 56°C, and the solution was continued to be pumped, so that a hot start was performed by heating at 96°C for 10 seconds, followed by 45 cycles of 96°C for 3 seconds and 56°C for 8 seconds. Under these conditions, the time required for 45 cycles of one-step reverse transcription real-time PCR was less than 10 minutes and 20 seconds.
[0075] As shown in Figure 7, the fluorescence intensity per cycle in rapid one-step reverse transcription real-time PCR showed a similar sigmoid curve regardless of the type of reverse transcriptase, as long as the initial concentrations of the norovirus G1 and G2 genes were the same, and the cycle numbers at which the fluorescence intensity rapidly amplified and increased were consistent for each.
[0076] Next, rapid one-step reverse transcription real-time PCR was examined by varying the initial concentrations of RNA of the G1 and G2 genes of norovirus, and the cycle number at which the fluorescence intensity rapidly increased and increased changed depending on the initial concentration for each of the G1 and G2 genes of norovirus, as shown in Figure 8. The cycle numbers at which the fluorescence intensity rapidly increased and increased were arranged in the order of the initial concentration of RNA, and therefore the initial concentration of RNA can generally be quantified by the Ct value, which is the cycle number at which the fluorescence intensity rapidly increased and increased.
[0077] However, in the amplification curve for the G1 gene of norovirus shown in Figure 8, it was confirmed that the baseline of the fluorescence intensity gradually increases in accordance with the thermal cycle, and then the fluorescence intensity increases rapidly from a certain cycle number. Therefore, it is difficult to estimate an accurate Ct value using the usual method of setting a certain value of fluorescence intensity as a threshold and using the cycle number exceeding that as the Ct value.
[0078] Therefore, in order to detect the Ct value at which high intensity rises and disappears appropriately during one-step reverse transcription real-time PCR even when the baseline is not a constant value, we decided to derive it from a matrix of fluorescence intensity measured for each thermal cycle number (two-dimensional array of amplification curves).
[0079] In order to detect a steep rise in the slope up to the Ct value of the two-dimensional array of the amplification curve, if the variation in fluorescence intensity is large, a moving average is performed as necessary, and a first-order differential in the forward direction is performed for each thermal cycle. In the new two-dimensional array related to the obtained slope, the root mean square (or a weighted average) of the initial slope (for example, 5 to 15 cycles, or the 5 to 15 cycles immediately preceding each cycle) is compared with the subsequent slope, and a significant increase (for example, 5-fold or more, but 2-fold or more is also acceptable) is detected. The Ct value was calculated as the cycle number at which the fluorescence intensity suddenly increased.
[0080] From the obtained Ct values, a calibration curve for the initial RNA concentrations of the G1 and G2 genes of norovirus was created, and the results are shown in Figure 9. Good linearity was obtained for each RNA concentration of the G1 and G2 genes of norovirus, and the Ct value could be determined promptly at the point when the fluorescence intensity suddenly increased, even during one-step reverse transcription real-time PCR, and the initial RNA concentration could be calculated from the Ct value.
[0081] The feature of the present invention is that the entire PCR solution passes through the fluorescence detection point through the flow path every cycle. Therefore, even if the fluorescent dye generated by real-time PCR does not have time to disperse evenly in the PCR solution due to the high speed of the thermal cycle and the fluorescent dye is unevenly distributed in the PCR solution as a concentration, all of the fluorescent dye is detected and integrated by the fluorescence detector, making it possible to accurately quantify the amount of fluorescence for each cycle.
[0082] Therefore, as shown in Figure 9, within the calibration range, the error bars of the Ct values in the measurements of each RNA concentration were very small, confirming that accurate quantification with excellent repeatability was possible even with high-speed one-step reverse transcription real-time PCR. [Industrial Applicability]
[0083] The device of the present invention is portable and can realize low-cost, high-speed, real-time PCR in clinical settings and at the site of infectious disease outbreaks. Specifically, it can enable rapid confirmation of treatment effectiveness and early detection of infectious diseases in livestock and poultry farming to prevent the spread of infection.
Claims
1. A reciprocal flow type nucleic acid amplification device comprising: a heater capable of forming a denaturation temperature zone and an extension / annealing temperature zone; a fluorescence detector capable of detecting the movement of a sample solution between the two temperature zones; a pair of liquid delivery mechanisms which enable the movement of the sample solution between the two temperature zones and which are released to atmospheric pressure when liquid delivery is stopped; a substrate on which a nucleic acid amplification chip can be mounted; and a control mechanism which receives an electrical signal from the fluorescence detector regarding the movement of the sample solution and controls the drive of each liquid delivery mechanism, and which performs real-time PCR by measuring the fluorescence intensity for each thermal cycle.
2. A nucleic acid amplification chip having at least one microchannel having curved flow channels corresponding to the denaturation temperature zone and the extension / annealing temperature zone in the nucleic acid amplification device of claim 1, a straight intermediate flow channel connecting the curved flow channels, and connection parts at both ends of the flow channel that can be connected to the liquid delivery mechanism in the nucleic acid amplification device of claim 1.
3. The nucleic acid amplifier according to claim 1 , wherein the liquid delivery mechanism is a microblower or an air blower.
4. A method for amplifying a nucleic acid, comprising the steps of: Step 1: placing the nucleic acid amplification chip according to claim 2 on the substrate according to claim 1 so that a curved flow path is included in each of a denaturation temperature zone and an extension / annealing temperature zone; Step 2: introducing a sample solution into the microchannel; Step 3: connecting the liquid delivery mechanism connectors at both ends of the microchannel to the pair of liquid delivery mechanisms; Step 4: A step of performing thermal cycling by using the liquid delivery mechanism to move the sample solution back and forth between two curved flow paths of the microflow path, and further performing real-time PCR by simultaneously measuring the fluorescence intensity of the sample solution for each thermal cycle and confirming the passage of the sample solution using the fluorescence detector in the intermediate flow path.
5. The nucleic acid amplification method according to claim 4, characterized in that the measurement of the fluorescence intensity is performed by simultaneously measuring two or more types of fluorescence wavelengths and simultaneously measuring real-time PCR of a plurality of genes in one flow channel. Width method.
6. The nucleic acid amplification method according to claim 4 or 5, characterized in that the measurement of the fluorescence intensity is performed using a calibration curve obtained from cycle number Ct values derived from a matrix of fluorescence intensity for each thermal cycle number (two-dimensional array of amplification curves).
7. The nucleic acid amplification method is polymerase chain reaction (PCR), reverse transcription PCR (RT-PCR), one-step RT-PCR, multiplex PCR or multiplex RT-PCR. The method for amplifying nucleic acid according to any one of claims 4 to 6, wherein the amplification method is selected from the group consisting of real-time PCR or real-time RT-PCR.
8. The nucleic acid amplification method according to any one of claims 4 to 7, characterized in that two or more of the flow channels are formed on a planar substrate, and each flow channel can be independently operated for liquid delivery, thereby performing interrupt analysis.
9. The nucleic acid amplification method according to any one of claims 4 to 8, wherein a tip of a filter-equipped pipette tip of a micropipette is connected to the connection part to introduce a sample solution into a microchannel, the micropipette is removed with the pipette tip connected to the connection part, and then the pipette tip is connected to the liquid delivery mechanism.
10. The volume of the sample solution introduced into the flow channel is in the range of 5 μL to 50 μL. Item 10. The method for amplifying nucleic acid according to any one of Items 4 to 9.
11. The nucleic acid amplification chip according to claim 2, which is used in the nucleic acid amplification method according to any one of claims 4 to 10.
Citation Information
Patent Citations
Reaction treatment method and reaction treatment apparatus
JP2009232700A
Working machine
JP2014007200A
Assay cartridge and method of use thereof
JP2014507937A
Reaction detection device
WO2009113356A1
Inspection system
WO2009125676A1
